REVIVA PHARMACEUTCLS HLDGS I's ticker is RVPHW and the CUSIP is 76152G118. A total of 13 filers reported holding REVIVA PHARMACEUTCLS HLDGS I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $239,000 | +7.7% | 1,251,250 | +1.3% | 0.01% | -22.2% |
| Q2 2022 | $222,000 | -33.3% | 1,235,000 | +1.2% | 0.01% | -18.2% |
| Q1 2022 | $333,000 | -22.0% | 1,220,600 | 0.0% | 0.01% | -21.4% |
| Q4 2021 | $427,000 | -12.5% | 1,220,600 | 0.0% | 0.01% | +7.7% |
| Q3 2021 | $488,000 | -21.3% | 1,220,600 | 0.0% | 0.01% | +18.2% |
| Q2 2021 | $620,000 | +10.5% | 1,220,600 | 0.0% | 0.01% | +22.2% |
| Q1 2021 | $561,000 | -31.9% | 1,220,600 | 0.0% | 0.01% | -50.0% |
| Q4 2020 | $824,000 | – | 1,220,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 200,000 | $1,749,000 | 0.06% |
| BlueCrest Capital Management Ltd | 1,220,600 | $824,000 | 0.02% |
| GLAZER CAPITAL, LLC | 690,166 | $466,000 | 0.02% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 110,900 | $75,000 | 0.01% |
| AQR Arbitrage LLC | 250,000 | $169,000 | 0.01% |
| Context Capital Management, LLC | 39,300 | $27,000 | 0.00% |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 106,552 | $72,000 | 0.00% |
| Walleye Capital LLC | 64,959 | $44,000 | 0.00% |
| Polar Asset Management Partners Inc. | 300,907 | $197,000 | 0.00% |
| HRT FINANCIAL LP | 132,624 | $89,000 | 0.00% |